J. Piotrowski et al., ENHANCEMENT IN GASTRIC-MUCOSAL EGF AND PDGF RECEPTOR EXPRESSION WITH ULCER HEALING BY SULGLYCOTIDE, General pharmacology, 26(4), 1995, pp. 749-753
1. The effect of an antiulcer agent, sulglycotide, on mucosal expressi
on of EGF and PDGF receptors with chronic ulcer healing was investigat
ed. 2. Rats with experimentally-induced gastric ulcers were treated tw
ice daily for 14 consecutive days, either with sulglycotide at 200 mg/
kg or vehicle, and at different stages of treatment used for quantitat
ion of gastric mucosal EGF and PDGF receptors. 3. The ulcer healing wa
s accompanied by an increase in mucosal expression of both types of re
ceptors. A 1.8-fold increase in EGF and 3.1-fold increase in PDGF rece
ptors occurred by the 4th day following the development of ulcer and r
eached a maximum of 2.4-3.9-fold increase by the 10-14th day. 4. Treat
ment with sulglycotide caused accelerated ulcer healing accompanied by
a significant enhancement in the receptors expression. A 2.3- and 3.6
-fold increase in EGF and PDGF receptor expression occurred by the 4th
day of sulglycotide treatment, reaching a 5.5- and 5.6-fold respectiv
e increase by the 10th day when the ulcer essentially healed. 5. The r
esults attest to the ability of sulglycotide to stimulate the gastric
mucosal proliferative activities associated with ulcer healing.